1672-2809
2015 Issue 1
Metformin time-honored evidence anddevelopmental chronology
gu wei jun ;, mu yi ming ;
gu wei jun ;, mu yi ming ;
..............page:4-8
Status of metformin in type 2 diabetesmellitus treatment from the perspective of guidelines change
cai xiao ling ;, ji li nong ;
cai xiao ling ;, ji li nong ;
..............page:9-13
Comprehensive evaluation the effectsof metformin on glucose control in patients with type 2 diabetes
zhou xiao ;, wang xu yi ;, sun zi lin ;
zhou xiao ;, wang xu yi ;, sun zi lin ;
..............page:14-18
Effect of combination therapy with insulinand metformin on type 2 diabetes
liu tao ;, fang yu jie ;, ji qiu he ;
liu tao ;, fang yu jie ;, ji qiu he ;
..............page:19-21,35
..............page:22-25
The use of metformin in specialdiabetic patients
li chun lin ;, miao xin yu ;
li chun lin ;, miao xin yu ;
..............page:26-29
Is heart failure the absolute contraindicationof metformin?
wang tong ;, xiao xin hua ;
wang tong ;, xiao xin hua ;
..............page:30-35
Development of cardiovascular protectiveeffects of metformin treatment
xiong zuo zuo ;, zhu da long ;
xiong zuo zuo ;, zhu da long ;
..............page:36-39
The debate on anti-tumor effect of metformin
sun hong ping ;, liu chao ;
sun hong ping ;, liu chao ;
..............page:40-43,48
Pharmacoeconomic evaluation aboutmetformin in type 2 diabetes mellitus
zhao su ;, yang wan hua ;
zhao su ;, yang wan hua ;
..............page:44-48
..............page:49-50